Clopidogrel Withdrawn Phase 3 Trials for Coronary Heart Disease (CHD) Basic Science

IndicationsStatusPurposePhase
WithdrawnBasic Science3
clinicaltrials.gov IdentifierTitleDrugs
NCT01757262A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese Patient